ArticleThoracic cancer2023

Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy.

Jung Hyun Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.